BELATI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 975
EU - Europa 805
AS - Asia 679
SA - Sud America 138
Continente sconosciuto - Info sul continente non disponibili 98
AF - Africa 35
OC - Oceania 2
Totale 2.732
Nazione #
US - Stati Uniti d'America 925
SG - Singapore 326
IT - Italia 311
DE - Germania 177
BR - Brasile 99
CN - Cina 82
HK - Hong Kong 75
FI - Finlandia 74
RU - Federazione Russa 64
BD - Bangladesh 60
FR - Francia 51
VN - Vietnam 50
GB - Regno Unito 31
SE - Svezia 27
CA - Canada 22
MX - Messico 19
NL - Olanda 16
CI - Costa d'Avorio 13
ES - Italia 12
ID - Indonesia 12
PL - Polonia 12
PH - Filippine 11
VE - Venezuela 11
AR - Argentina 10
IN - India 10
ZA - Sudafrica 10
IQ - Iraq 9
PK - Pakistan 8
LT - Lituania 7
CO - Colombia 6
CZ - Repubblica Ceca 6
TR - Turchia 6
CL - Cile 5
EC - Ecuador 5
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
SA - Arabia Saudita 4
TN - Tunisia 4
AT - Austria 3
JP - Giappone 3
UA - Ucraina 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
PE - Perù 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MZ - Mozambico 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 2.634
Città #
Singapore 212
Ashburn 161
San Jose 134
Munich 127
Hong Kong 75
Milan 68
Council Bluffs 62
Helsinki 62
Los Angeles 45
Beijing 41
Rome 40
New York 32
Columbus 26
Lauterbourg 26
Falkenstein 24
Santa Clara 22
Bari 21
Boardman 21
Buffalo 20
Nyköping 19
Chandler 16
Chicago 16
Dallas 15
Frankfurt am Main 14
Ho Chi Minh City 14
Abidjan 13
Brooklyn 12
London 11
Atlanta 9
Houston 9
Phoenix 9
Turku 9
Warsaw 9
Hanoi 8
Mexico City 8
Stockholm 8
São Paulo 8
Jakarta 7
Montreal 7
Toronto 7
Brno 6
Figino 6
Orem 6
Curitiba 5
Detroit 5
Düsseldorf 5
Nuremberg 5
Salt Lake City 5
Tampa 5
Turin 5
Baltimore 4
Brasília 4
Caracas 4
Da Nang 4
Johannesburg 4
Modugno 4
Monza 4
Moscow 4
Poplar 4
Rio de Janeiro 4
San Francisco 4
Seattle 4
Wilmington 4
Amman 3
Boston 3
Cape Town 3
Charlotte 3
City of London 3
Contagem 3
Fairfield 3
Guayaquil 3
Jyväskylä 3
Manila 3
Naples 3
Palermo 3
Pomigliano d'Arco 3
Querétaro 3
Rosà 3
Tokyo 3
Vancouver 3
Woodbridge 3
Amsterdam 2
Angri 2
Avon 2
Barletta 2
Bologna 2
Chennai 2
Cássia 2
Denver 2
Dhaka 2
Dublin 2
Elk Grove Village 2
Haiphong 2
Jeddah 2
Jenin 2
Jersey City 2
Karachi 2
Kathmandu 2
Lawrence 2
Lucca 2
Totale 1.644
Nome #
First Case of Paraphimosis as a Severe Complication of Monkeypox 242
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 155
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 150
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 146
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 125
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study 122
Occurrence of Acute Pulmonary Embolism in COVID-19—A case series 121
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" Study 119
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study 108
Prompt and Appropriate Antimicrobial Therapy Improves Outcomes of NDM-Producing and KPC-Producing Klebsiella pneumoniae Bloodstream Infections in Patients Hospitalized for COVID-19: A Comparative Retrospective Case-Series 102
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review 101
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 96
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study 91
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study 90
Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature review 89
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study 89
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study 83
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections 81
First-line combination therapy with fifth generation cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant Staphylococcus aureus bacteraemia: a multicenter retrospective cohort study 73
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 71
Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study 71
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study 69
Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options 67
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients 67
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 58
Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication 47
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study 45
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 39
Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes? 10
Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era 5
Totale 2.732
Categoria #
all - tutte 10.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 1 1 0 1 3 0 1 2
2022/202361 2 6 2 2 10 9 0 15 6 1 1 7
2023/202489 7 21 4 11 7 13 0 7 1 2 3 13
2024/2025671 26 14 7 21 16 80 116 92 47 66 60 126
2025/20261.676 180 48 76 175 211 119 158 65 192 158 79 215
2026/2027192 73 82 37 0 0 0 0 0 0 0 0 0
Totale 2.732